Alzheimer’s disease (AD) is a multifactorial disease characterized by numerous pathologies including increased neuroinflammation, decreased synaptic plasticity, dysregulated amyloid precursor protein (APP) processing, and aberrant tau protein post-translational modifications [1]. This evidence concerns the gene APP and Alzheimer disease.